Tysabri decision will wait until second half of 2005
Biogen Idec and Elan do not expect to issue a decision on the fate of their jointly-marketed multiple sclerosis (MS) ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.